SAM BENSON: Open Payments
NPI 1265859516 · NORTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 44 payments from 18 companies in 2025. Trend: 2023 $203 · 2024 $101 · 2025 $1,111
Food & beverage: $1,111
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $184 |
| Astellas Pharma US Inc | 2 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $157 |
| ABBVIE INC. | 4 | $107 |
| Sumitomo Pharma America, Inc. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Novo Nordisk Inc | 3 | $60 |
| Exact Sciences Corporation | 3 | $54 |
| Lilly USA, LLC | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
Products named: Veozah, Kerendia, ZAVZPRET, LINZESS, GEMTESA, ELIQUIS, Ozempic, FARXIGA.
Industry payments across FL — which companies pay providers there.
